Can a Pharmacist's guidance with a glucose monitor improve diabetes control?
NCT ID NCT06572306
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times
Summary
This pilot study tests whether having a pharmacist oversee continuous glucose monitoring (using a FreeStyle Libre device) can improve blood sugar control and health behaviors in people with type 2 diabetes. Forty participants will use the monitor for 12 weeks, and their results will be compared to a historical group that only used standard finger-stick testing. The study aims to see changes in A1c levels and other glucose measures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- FreeStyle Libre 2/Libre 3+ Continuous Glucose Monitor (device)
- What this could lead to
- If successful, this could show that pharmacist-led continuous glucose monitoring helps people with type 2 diabetes better manage their blood sugar and adopt healthier habits.
- What could go wrong
- This is a small pilot study with only 40 participants, so results may not apply to everyone. It compares to a historical group, not a randomized control, which limits reliability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
USF Health Department of Family Medicine
Tampa, Florida, 33612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?
- Does when you eat carbs and protein reshape blood sugar control?